Daiichi Sankyo to seek approval of influenza drug
"Daiichi Sankyo Co (4568.T), Japan's third-largest drugmaker, said it plans to apply by March 2010 for marketing approval in Japan of an influenza drug candidate, and seek approval in Taiwan, Hong Kong and South Korea soon afterwards."
""Prompted by rapidly increasingly needs for new influenza treatment, we have sped up the development of the drug and are now set to complete all our six lines of clinical tests, three for use in adults and three for children, by March," said Daiichi Sankyo director Daisuke Hiro."
http://www.reuters.com/article/rbssHealthcareNews/idUST18357620090123
- Forums
- ASX - By Stock
- BTA
- positive drivers on the way
positive drivers on the way, page-4
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BTA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
1CG
ONE CLICK GROUP LIMITED
Mark Waller, MD
Mark Waller
MD
SPONSORED BY The Market Online